{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:27:16Z","timestamp":1762885636742,"version":"3.45.0"},"reference-count":16,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fundo de Incentivo \u00e0 Pesquisa e Eventos \u2013 Hospital de Cl\u00ednicas de Porto Alegre","award":["2019\u20130081"],"award-info":[{"award-number":["2019\u20130081"]}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Bevilacqua IP by CAPES"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"\n Introduction<\/jats:title>\n Hereditary Spastic Paraplegias (HSP) are a group of genetic disorders leading to the degeneration of long motor and sensory tracts in a progressive course. Clinician-reported outcomes (ClinROs) are the most commonly used endpoints for monitoring these diseases, but they have low sensitivity to detect progression. Therefore, identifying new monitoring biomarkers with higher sensitivity to change is crucial. Our objective was to compare the progression of Somatosensory Evoked Potential (SSEP) latencies over time with ClinROs in HSP.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n A longitudinal study was conducted on 22 individuals with a genetic diagnosis (13 SPG4, 3 SPG5, 3 SPG7, 2 SPG10, and 1 cerebrotendinous xanthomatosis), with two evaluations over a 4-year interval of upper limb (UL) and lower limb (LL) SSEPs and the Spastic Paraplegia Rating Scale (SPRS) total score and motor items only (mSPRS).<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n In the follow-up time analysis, progression after 4 years was observed only for SPRS and mSPRS, with an annual progression of 1.12 points and 1.02 points, respectively. No statistically significant progression was observed for SSEPs. Disease progression modeled according to disease duration showed worsening in all outcomes. For each additional year of disease, the SPRS worsened by 0.834 points (95% CI 0.62 to 1.04, p\u2009<\u20090.001), mSPRS by 0.758 points (95% CI 0.55 to 0.96, p\u2009<\u20090.001), SSEP-UL latency by 0.164 ms (95% CI 0.03 to 0.3, p\u2009<\u20090.001), and SSEP-LL latency by 1.343 ms (95% CI 0.74 to 1.93, p\u2009<\u20090.001). Results for the SPG4 subgroup were similar to those for the overall HSP group.<\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n The neurophysiological progression of sensory long tract dysfunction is even slower than the progression of motor findings measured by COAs in HSP. The low sensitivity to change of SSEPs identified suggests that they should not be used as primary endpoints in future clinical trials for disease-modifying drugs.<\/jats:p>\n <\/jats:sec>","DOI":"10.1371\/journal.pone.0335187","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:23:58Z","timestamp":1762885438000},"page":"e0335187","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Limited sensitivity of somatosensory evoked potentials as disease monitoring biomarkers in hereditary spastic paraplegias"],"prefix":"10.1371","volume":"20","author":[{"given":"Fernando Augusto Marion","family":"Spengler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samanta Ferraresi","family":"Brighente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Luiza","family":"Rodrigues Louzada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Eduarda Ribeiro","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabela Possebon","family":"Bevilacqua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana Maria","family":"Cubillos-Arcila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1141-6573","authenticated-orcid":true,"given":"Jonas Alex Morales","family":"Saute","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"pone.0335187.ref001","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/B978-0-323-98817-9.00022-3","article-title":"The hereditary spastic paraplegias","volume":"196","author":"JK Fink","year":"2023","journal-title":"Handb Clin Neurol"},{"issue":"2","key":"pone.0335187.ref002","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000664","article-title":"Clinical-Genetic Features Influencing Disability in Spastic Paraplegia Type 4: A Cross-sectional Study by the Italian DAISY Network","volume":"8","author":"S Rossi","year":"2022","journal-title":"Neurol Genet"},{"issue":"1","key":"pone.0335187.ref003","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s12311-023-01518-4","article-title":"Static Balance in Hereditary Spastic Paraplegias: a Cross-sectional Study","volume":"23","author":"DM Cubillos-Arcila","year":"2024","journal-title":"Cerebellum"},{"issue":"9","key":"pone.0335187.ref004","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.3390\/genes14091756","article-title":"Outcome Measures and Biomarkers for Clinical Trials in Hereditary Spastic Paraplegia: A Scoping Review","volume":"14","author":"S-F Siow","year":"2023","journal-title":"Genes (Basel)"},{"issue":"1","key":"pone.0335187.ref005","doi-asserted-by":"crossref","first-page":"22248","DOI":"10.1038\/s41598-021-01635-2","article-title":"Clinical and molecular characterization of a large cohort of childhood onset hereditary spastic paraplegias","volume":"11","author":"GM Giordani","year":"2021","journal-title":"Sci Rep"},{"issue":"12","key":"pone.0335187.ref006","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1093\/brain\/awx273","article-title":"Hereditary spastic paraplegia type 5: natural history, biomarkers and a randomized controlled trial","volume":"140","author":"L Sch\u00f6ls","year":"2017","journal-title":"Brain"},{"issue":"1","key":"pone.0335187.ref007","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000200052","article-title":"Toward the Definition of Patient-Reported Outcome Measurements in Hereditary Spastic Paraplegia","volume":"9","author":"M Amprosi","year":"2023","journal-title":"Neurol Genet"},{"key":"pone.0335187.ref008","doi-asserted-by":"crossref","first-page":"1226479","DOI":"10.3389\/fnins.2023.1226479","article-title":"Long-term progression of clinician-reported and gait performance outcomes in hereditary spastic paraplegias","volume":"17","author":"DM Cubillos Arcila","year":"2023","journal-title":"Front Neurosci"},{"issue":"11","key":"pone.0335187.ref009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0259397","article-title":"Evoked potentials as biomarkers of hereditary spastic paraplegias: A case-control study","volume":"16","author":"SF Brighente","year":"2021","journal-title":"PLoS One"},{"issue":"4","key":"pone.0335187.ref010","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.brainresbull.2007.06.018","article-title":"Motor and somatosensory evoked potentials in Autosomal Dominant Hereditary Spastic Paraparesis (ADHSP) linked to chromosome 2p, SPG4","volume":"74","author":"F Sartucci","year":"2007","journal-title":"Brain Res Bull"},{"key":"pone.0335187.ref011","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1750-1172-8-158","article-title":"Electrophysiological characterisation of motor and sensory tracts in patients with hereditary spastic paraplegia (HSP)","volume":"8","author":"KN Karle","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"pone.0335187.ref012","doi-asserted-by":"crossref","first-page":"1198728","DOI":"10.3389\/fneur.2023.1198728","article-title":"Clinical analysis in patients with SPG11 hereditary spastic paraplegia","volume":"14","author":"Y-R Kang","year":"2023","journal-title":"Front Neurol"},{"issue":"4","key":"pone.0335187.ref013","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.clinph.2010.10.025","article-title":"Electrophysiological characterisation in hereditary spastic paraplegia type 5","volume":"122","author":"F Manganelli","year":"2011","journal-title":"Clin Neurophysiol"},{"key":"pone.0335187.ref014","doi-asserted-by":"crossref","first-page":"117211","DOI":"10.1016\/j.jns.2020.117211","article-title":"Elevated hydroxycholesterols in Norwegian patients with hereditary spastic paraplegia SPG5","volume":"419","author":"S Prests\u00e6ter","year":"2020","journal-title":"J Neurol Sci"},{"issue":"6","key":"pone.0335187.ref015","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/brain\/awz102","article-title":"FAHN\/SPG35: a narrow phenotypic spectrum across disease classifications","volume":"142","author":"TW Rattay","year":"2019","journal-title":"Brain"},{"issue":"3","key":"pone.0335187.ref016","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1212\/01.wnl.0000228242.53336.90","article-title":"The Spastic Paraplegia Rating Scale (SPRS): a reliable and valid measure of disease severity","volume":"67","author":"R Sch\u00fcle","year":"2006","journal-title":"Neurology"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0335187","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:24:04Z","timestamp":1762885444000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0335187"}},"subtitle":[],"editor":[{"given":"Jian","family":"Jing","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":16,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0335187","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]}}}